Humira, Enbrel, Rinvoq, Xeljanz, and Orencia all require prior authorization, step therapy documentation, and payer-specific lab evidence. A single missing field denies the claim and delays care by weeks.
| Drug / Class | Common Denial Reason | PriorZap Prevention |
|---|---|---|
| Humira (adalimumab) | No documented MTX failure | Step therapy failure auto-documented from FHIR Rx history |
| Rinvoq (upadacitinib) | JAK inhibitor safety screening missing | Lab order checklist triggered at prescribing |
| Xeljanz (tofacitinib) | Black box warning not acknowledged | Risk acknowledgment embedded in CDS alert |
| Orencia (abatacept) | DAS28 score not in documentation | Disease activity score pulled from structured notes |
| Cimzia (certolizumab) | Pregnancy status not documented for female patients | FHIR demographics trigger required fields |
| Enbrel (etanercept) | Not covered by Medicaid for stated ICD-10 | Payer-specific diagnosis validation at order entry |
Prevent biologic denials before the order leaves your EHR. PriorZap checks step therapy compliance, lab results, and payer criteria in real time — inside Epic, Oracle Health, or athenahealth.